Alabama settles opioid claims against J&J, distributors for $276 mln - attorney general
19/04/2022 18:49
April 19 (Reuters) - Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson JNJ.N , McKesson Corp MCK.N and Endo Pharmaceutical ENDP.O , resolving the state's claims that the companies fueled an opioid addiction crisis, the state Attorney General said. (Reporting by Dietrich Knauth) ((Dietrich.Knauth@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes